Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$7 Hold
2
– – ﹤0.01% 3454
2026
Q2
$12 Buy
+2
New +$14 ﹤0.01% 3407
2025
Q2
– Hold
0
– -$1 – 2794
2025
Q1
– Hold
0
– – – 2663
2024
Q4
– Hold
0
– – – 2601
2024
Q3
– Hold
0
– – – 2602

Other funds holding PAVM

BFC Planning's PAVM Position: Q3 2026 in Review

BFC Planning held its PAVmed (PAVM) position steady in Q3 2026 at 2 shares worth $7. The position accounts for ﹤0.01% of the portfolio, ranked #3454.

BFC Planning first reported a position in PAVM in Q2 2026 and has held it in 2 quarters since. The position peaked at $12 in Q2 2026. 17 funds tracked by Wall St. Rank hold PAVM as of Q3 2026.

  • BFC Planning held 2 shares of PAVmed worth $7 as of Q3 2026.
  • BFC Planning left its PAVmed share count unchanged in Q3 2026.
  • PAVmed made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #3454 holding.
  • BFC Planning first reported a position in PAVmed in Q2 2026 and has held it in 2 quarters since.
  • BFC Planning's PAVmed position peaked at $12 in Q2 2026.
  • 17 funds tracked by Wall St. Rank held PAVmed as of Q3 2026.

Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.